Dr. Satya Vadlamani : Addressing anemia through Transdermal Oil – Interventions at 15th Annual Pharma Leaders 2022
Dr. Satya Vadlamani, Chairperson and Managing Director, Murli Krishna Pharma Private Ltd addressing on Transdermal Oil - Interventions for Addressing Anemia Among Children and Adolescents – A Murli Krishna Pharma Case Study at the at the 15th Annual…
The Changemakers: Dr. Satya Ramani Vadlamani, CMD – Murli Krishna Pharma Pvt. Ltd
From establishing and leading Murli Krishna Pharma to change the Pharma landscape of India, Dr. Vadlamani has touched and transformed lives with her sheer passion, grit and determination. From being a Regulatory Compliant prefinished formulation…
Dr. Satya Vadlamani – NexBrands Brand Vision Summit 2022
Dr. Satya Vadlamani, Founder, Chairperson & Managing Director of Murli Krishna Pharma Pvt. Ltd. addressing NexBrands Brand Vision Summit 2022
Dr Satya Vadlamani Addressing on Healthcare Reforms at India Leadership Conclave 2021
Dr. Satya Vadlamani, Founder, Chairperson & Managing Director of Murli Krishna Pharma Pvt. Ltd. addressing on Healthcare Reforms at the 12th Annual India Leadership Conclave & Indian Affairs Power Brand Awards 2021.
Dr.Satya Vadlamani voted as Indian Affairs Inspirational Women Business Reformer of the Year 2021
Dr.Satya Vadlamani,Chairperson & Managing Director, Murlikrishna Pharma Pvt.Ltd. voted as Indian Affairs Inspirational Women Business Reformer of the Year 2021 at the iconic & prestigious 12th Annual India Leadership Conclave & Indian…
A step towards Anemia Mukt Bharat
A step towards Anemia Mukt Bharat New Delhi [India], January 3 (ANI/GIPR): Dr Satya Vadlamani's contribution towards the building of the nation is immense, as apparent in the past more than two decades, which she has dedicated to bringing smiles to…
Satya Vadlamani at Icons of Healthcare 2017
Satya Vadlamani set up Murli Krishna Exports ( A Pharmaceutical API's Marketing and Trading Company) in 1997. Murli Krishna Pharma Pvt. Ltd. was started by Satya Vadlamani and Dr.Vijay Shastri in 2004 with a group of 4 Directors. The Plant was…
